More articles from Neurosciences

You have access
PET-CT shows advantage of Intra-Arterial vs. Intravenous Delivery of PAMAM Dendrimers for targeting the brain but their accumulation is transient
Wojciech Lesniak, Chengyan Chu, Anna Jablonska, Babak Behnam Azad, Martin Pomper, Piotr Walczak and Miroslaw Janowski

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 116;
You have access
Fluorinated Cromolyn Derivatives for Potential Alzheimer’s Disease Treatment
Timothy Shoup, Marc Normandin, Kazue Takahashi, Ana Griciuc, Maeva Dhaynaut, Luisa Quinti, Sung-Hyun Moon, Nicolas Guehl, Pedro Brugarolas, Rudolph E Tanzi, Georges El Fakhri and David Elmaleh

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 114;
You have access
Imaging the invaders: TREM1 as a novel PET imaging biomarker of peripheral infiltrating myeloid cells and potential therapeutic target in multiple sclerosis.
Aisling Chaney, Haley Cropper, Emily Johnson, Marc Stevens and Michelle James

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1506b;
You have access
Single dose whole brain irradiation causes glial activation and increased cerebral blood flow in rats: a longitudinal PET/SPECT imaging study
Elisa Maciel, Andrea Parente, Janine Doorduin and Erik de Vries

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 184;
You have access
High resolution [¹⁸F]FDG PET of the inferior colliculi in single-sided deafness.
Iva Speck, Susan Arndt, Johannes Thurow, Ganna Blazhenets, Thomas Wesarg, Roland Laszig, Philipp Meyer and Lars Frings

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 421;
You have access
Assessing global and regional Aβ-amyloid deposition in the brain with multiple Aβ-tracers using the Centiloid scale
Victor Villemagne, Samantha Burnham, Pierrick Bourgeat, Vincent Dore, Simon Laws, Olivier Salvado, Jurgen Fripp, Ralph Martins, Colin Masters and Christopher Rowe

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 248;
You have access
First-in-human Evaluation of ¹⁸F-SDM-8, A Novel Radiotracer for PET Imaging of Synaptic Vesicle Glycoprotein 2A
Songye Li, Mika Naganawa, MingQiang Zheng, Richard Pracitto, Shannan Henry, David Matuskey, Michael Kapinos, Paul Emery, Zhengxin Cai, Jim Ropchan, David Labaree, Nabeel Nabulsi, Richard Carson and Yiyun Huang

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 49;
You have access
Hybrid PET-MR Imaging in Dementia: Is There a Difference Comparing Patterns of FDG Hypometabolism to Age-Matched versus Non-Age Matched Controls?
Kiyon Naser-Tavakolian, Michael Clifton, Ernest Batista, Osama Ahmed, Dinko Franceschi, Giuseppe Cruciata, Lev Bangiyev, Avraham Bluestone and Ana Franceschi

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1454;
You have access
Combined cut-off point determination of ¹⁸F-AV-1451 (T807) imaging biomarker for tau burden and 2018 NIA-AA definition facilitate reclassification of Alzheimer’s disease
Ivan Ho, Sirong Chen, Yim Lung Leung, Man Ki Cheung, Chi-Lai Ho and Vincent Mok

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 254;
You have access
Imaging biomarkers correlate with efficacy of bevacizumab combined with conventional therapy in newly diagnosed glioblastoma: an open-label, single arm trial
Li Li, Shuanghu Yuan, Jinming Yu, Ning Liu, Zhang Hui, Rongjie Tao, Shuqiang Zhao, Liang Xu, Yuhui Liu and Yongsheng Gao

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 492;

Main menu

User menu

Search

More articles from Neurosciences

Pages